FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity

"The threat of antimicrobial-resistant infections is a key challenge we face as a public health agency," said FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D.